BOSTON, MASS – The story of the baby born with HIV in Mississippi, treated intensively and immediately, only to be lost to care for five months before turning up healthy, is dominating talk at the Conference on Retroviruses and Opportunistic Infections for a second year, with news that the child continues to show no sign […]
BOSTON, MASS – Gavin Churchyard and Katherine Fielding presented results this morning from the XPert for TB: Evaluating a New Diagnostic Trial (EXTEND) on the question of whether Xpert MTB/RIF diagnostic test reduces early mortality in adults with suspected TB, facilitates earlier initiation of TB treatment and antiretroviral therapy and reduces the number of patients […]
BOSTON, MASS – A discussion launched by findings from researchers working in Africa and India Tuesday focused on the quest to keep people living with HIV in care, and on measures to improve their outcomes. Elvin Geng and colleagues looked at more than 35,000 patients in 14 clinics operated by 5 programs in East Africa […]
BOSTON, MASS. – On one hand, researchers had trial participants’ reports that they could, would and had used the products being tested to determine their potential for preventing HIV acquisition — whether pills or vaginal gels — and to back that up they had the unused pills and gel applicators the women returned. On the […]
HIV
To control the global health threat of HIV by 2030, according to UNAIDS, these goals must be reached by 2020: To diagnose 90 percent of all […]
Tuberculosis
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With more than 112,000 cases of measles reported by 170 countries so far this year, the world is seeing rising rates of a vaccine-preventable illness over […]